Phase II study of gemcitabine plus vinor
✍
Chuan-Cheng Wang; Jang-Yang Chang; Tsang-Wu Liu; Chin-Yu Lin; Yu-Chieh Yu; Ruey-
📂
Article
📅
2006
🏛
John Wiley and Sons
🌐
English
⚖ 90 KB
Background. A phase II study was conducted to evaluate the safety and efficacy of a gemcitabine plus vinorelbine combination (GV) for patients with cisplatin-resistant nasopharyngeal carcinoma (NPC). Methods. Thirty-nine eligible patients received vinorelbine, 20 mg/m 2 , followed by gemcitabine, 1